CALGARY, Alberta, Jan. 27, 2015 /PRNewswire/ -- The global healthcare analytics market is currently estimated at $4.8 billion, with a projected growth to more than $10 billion over the next three years. As this market grows, the need for a standardized method for data collection and management is increasing. Vivametrica today announced that it has reached critical milestones in company growth in 2014, making significant strides to meet this exploding market demand.
Since launching last year, Vivametrica's unique data analytics approach has been well received, further validating the impact and importance of these devices in healthcare.
- Research based algorithms: Vivametrica's analysis is based on years of comprehensive clinical findings in the fields of physical activity, rehabilitation and medicine. The company has now built several proprietary risk assessment algorithms and completed its technology road map, which will lead to an API offering that provides licensed analysis capabilities and integrates seamlessly across mobile apps and popular wearable devices. Additionally, Vivametrica's research group is now refining an evidence-based, secure, self-administered testing protocol for heart health based on data collected from wearables.
- Enterprise-focused path to market: After extensive surveys that revealed the market demand for healthcare-based analytics, Vivametrica released its first product for the enterprise vertical, the Functional Activity Assessment. Vivametrica has plans to expand the offering for additional markets including, medical-legal, corporate health and wellness programs, insurance providers and clinical health organizations.
- Venture-backed: The team was invited to pitch at several venture capitalist events in Canada and was awarded the Top VC Prospect award from the A100. Additionally, Vivametrica closed a successful seed round in less than six weeks, with plans to open a second round in the first quarter of 2015.
Dr. Richard Hu, founder and CEO of Vivametrica, said: "From a physician's point of view, health wearables are only as useful as the data they generate. Our goal in pioneering a standardized process is to create a new approach to health management by analyzing data in a way that is meaningful and actionable for individuals and care providers. We are encouraged by the strides we have made in a short span of time and are spurred on by our many supporters to continue creating a device-agnostic product that serves all stakeholders. We anticipate driving this momentum forward in 2015 by solidifying strategic partnerships and launching several new pilot projects."
Vivametrica provides a first of its kind analytics platform for wearable healthcare. Its device agnostic platform delivers a standardized approach to data collection and management, bridging the gap between wearable fitness applications and actionable data for consumers, enterprises, healthcare and researchers. Created by physicians and researchers, Vivametrica's approach is based on comprehensive clinical findings in the fields of physical activity, rehabilitation and medicine. For more information, visit www.vivametrica.com.
Nadel Phelan, Inc.